Skip to content

Bipolar Interactive PsychoEDucation trial

An exploratory (phase II) trial of a novel interactive psychoeducational intervention for bipolar disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN81375447
Enrollment
100
Registered
2008-11-20
Start date
2009-04-01
Completion date
Unknown
Last updated
2018-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar disorder Mental and Behavioural Disorders Bipolar affective disorder

Interventions

BEATING BIPOLAR is a novel interactive psychoeducational intervention. It involves a blending of different delivery mechanisms, with initial face-to-face delivery to focus on engagement, followed by w

Sponsors

Cardiff University (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Diagnostic and Statistical Manual of Mental Disorders - Fourth Edition (DSM-IV) criteria of bipolar disorder (including type I and type II) 2. Male and female 3. Aged between 18 - 65 years

Exclusion criteria

Exclusion criteria: Inability to engage fully in the psychoeducational programme (for example, because of cognitive impairment or not having English language of sufficient ability).

Design outcomes

Primary

MeasureTime frame
Quality of life, assessed using the World Health Organization Quality of Life Questionnaire (WHOQOL-Bref). Outcome assessments will occur 6 months after the end of the intervention.

Secondary

MeasureTime frame
1. Global Assessment of Functioning (GAF) scores 2. Functioning Assessment Short Test (FAST) scores 3. Schedule of Assessment of Insight (SAI) scores 4. Current depressive symptoms according to the Montgomery-Asberg Depression Rating Scale (MADRS) and current manic symptoms according to the Young Mania Rating Scale (YMRS) scale 5. All participants will be re-assessed using the Mini International Neuropsychiatric Interview (MINI) applied to the 6 month follow-up period in order to obtain information about the number and severity of depressive and manic symptoms and number of episodes of depression and mania or hypomania experienced during this follow-up period 6. Cost-effectiveness analysis of the intervention Outcome assessments will occur 6 months after the end of the intervention.

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 2, 2026